Cambrex Corporation (NYSE:CBM) reported earnings of $0.74 per share beating Walls Streets expectations.

Cambrex Corporation (NYSE:CBM) reported Q2 2018 earnings this Morning, coming in at $0.74 per share, beating Wall Street’s estimates of $0.69 per Share. Revenue for the quarter came in at $152.05 million beating analyst estimates of $132.78 million

Recent Insider Trading for Cambrex Corporation (NYSE:CBM)

  • On 8/1/2018 Steven M Klosk, CEO, sold 55,000 with an average share price of $62.46 per share and the total transaction amounting to $3,435,300.00.
  • On 7/2/2018 Steven M Klosk, CEO, sold 55,000 with an average share price of $51.73 per share and the total transaction amounting to $2,845,150.00.
  • On 6/11/2018 Steven M Klosk, CEO, sold 55,000 with an average share price of $45.64 per share and the total transaction amounting to $2,510,200.00.
  • On 5/8/2018 Gregory Sargen, EVP, sold 67,500 with an average share price of $49.48 per share and the total transaction amounting to $3,339,900.00.
  • On 5/8/2018 Shawn Cavanagh, COO, sold 40,000 with an average share price of $49.69 per share and the total transaction amounting to $1,987,600.00.
  • On 10/2/2017 Steven M Klosk, CEO, sold 4,000 with an average share price of $54.96 per share and the total transaction amounting to $219,840.00.
    Story continues below



    About Company
    Cambrex Corporation, a life sciences company, provides various products and services for the development and commercialization of new and generic therapeutics worldwide. Its products comprise active pharmaceutical ingredients and pharmaceutical intermediates that are used in the production of prescription and over-the-counter drug products, as well as other fine chemicals. The company serves generic drug companies; and companies that discover and commercialize small molecule human therapeutics. The company sells its products directly, as well as through independent agents. Cambrex Corporation was founded in 1981 and is headquartered in East Rutherford, New Jersey.

    Recent Analyst Rating for Cambrex Corporation (NYSE:CBM)



      Recent Trading for Cambrex Corporation (NYSE:CBM)
      Shares of Cambrex Corporation closed the previous trading session at 66.15 up +3.40 5.42% with 62.15 shares trading hands.

      An ad to help with our costs